These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6748088)

  • 21. Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms.
    Khalil A; Carrier M; Latour JG; Pelletier LC
    Circulation; 1996 Nov; 94(9 Suppl):II308-11. PubMed ID: 8901766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs.
    Kuhn FE; Johnson MN; Gillis RA; Visner MS; Schaer GL
    J Am Coll Cardiol; 1990 Nov; 16(6):1481-91. PubMed ID: 2229802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cardiac glycosides on the coronaries: physiologic and morphologic studies in the dog heart.
    Sótonyi P; Juhász-Nagy A
    Acta Physiol Hung; 1984; 63(2):153-60. PubMed ID: 6741562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise.
    Laxson DD; Homans DC; Bache RJ
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1471-7. PubMed ID: 8238557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine deaminase attenuates canine coronary vasodilation during systemic hypoxia.
    Merrill GF; Downey HF; Jones CE
    Am J Physiol; 1986 Apr; 250(4 Pt 2):H579-83. PubMed ID: 3963215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary metabolic adaptation restricted by endothelin in the dog heart.
    Fazekas L; Kékesi V; Soós P; Barát E; Huszár E; Juhász-Nagy A
    Acta Physiol Hung; 2001; 88(1):35-46. PubMed ID: 11811845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracoronary linsidomine abolishes acetylcholine-induced vasoconstriction of epicardial coronary arteries.
    Dubois-Rande JL; Dupouy P; Geschwind H; Castaigne A; Adnot S
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):462-7. PubMed ID: 7504139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased flow reserve in "stunned" myocardium after a 10-min coronary occlusion.
    Triana JF; Bolli R
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H793-804. PubMed ID: 1887925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increases in coronary vascular resistance related to high arterial oxygen tension in dogs.
    Ishikawa K; Kanamasa K; Yamakado T; Kohashi Y; Kato A; Otani S; Hayashi T; Katori R
    Jpn Circ J; 1980 Sep; 44(9):749-54. PubMed ID: 7411838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vessel tone affects transmural distribution of coronary flow during hypoperfusion.
    Buffington CW; Watanabe S
    Am J Physiol; 1995 Mar; 268(3 Pt 2):H1284-92. PubMed ID: 7900883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine-induced coronary effects in the dog heart attributed to beta- and alpha-adrenergic mechanisms.
    Rabloczky G; Kékesi V; Mader MR; Juhász-Nagy A
    Arch Int Pharmacodyn Ther; 1988; 293():109-26. PubMed ID: 2844127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence from bioassay studies indicating a role for adenosine in cardiac ischemic and hypoxic dilation in the dog.
    Scott JB; Chen WT; Swindall BT; Dabney JM; Haddy FJ
    Circ Res; 1979 Oct; 45(4):451-9. PubMed ID: 476868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
    Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
    J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nitroglycerin on the coronary microcirculation in normal and ischemic myocardium.
    Kanatsuka H; Eastham CL; Marcus ML; Lamping KG
    J Cardiovasc Pharmacol; 1992 May; 19(5):755-63. PubMed ID: 1381774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses.
    Heusch G; Deussen A
    J Cardiovasc Pharmacol; 1984; 6(3):378-83. PubMed ID: 6202961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise.
    Duncker DJ; Laxson DD; Lindstrom P; Bache RJ
    Cardiovasc Res; 1993 Sep; 27(9):1592-7. PubMed ID: 8287435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of alpha 1- and alpha 2-adrenoceptors in the coronary vasoconstrictor responses to neuronally released and exogenous noradrenaline in the dog.
    Woodman OL
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):161-8. PubMed ID: 2891038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation.
    Cason BA; Shubayev I; Hickey RF
    Anesthesiology; 1994 Nov; 81(5):1245-55; discussion 27A-28A. PubMed ID: 7978484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nickel ions and ischemic coronary vasoconstriction.
    Rubanyi G; Ligeti L; Koller A; Kovach AG
    Bibl Cardiol; 1984; (38):200-8. PubMed ID: 6099723
    [No Abstract]   [Full Text] [Related]  

  • 40. Compensation of endothelin-1-induced coronary vasoconstriction.
    Fazekas L; Szabó T; Barát E; Huszár E; Kékesi V; Juhász-Nagy A
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S106-8. PubMed ID: 9595413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.